Electronic skin (E‐skin) is an emerging and promising human‐machine interface. Besides skin‐like functions of tactile perception and stretchability, skin‐like comfortabilities, including breathability, moisture permeability, softness, and thermoregulating ability are, also crucial factors for E‐skins. Thermoregulation is one of the most important roles of human skin. People can feel comfortable when their skins are regulated at a certain range of temperature. Moreover, it is a dynamic process according to the surrounding temperature. Current E‐skins do not have the function of dynamically regulating their temperature. Here, a thermoregulating E‐skin (TE‐skin) based on liquid metal as a phase change material with its melting point in the comfortable temperature range of human skin is reported. Compared with conventional E‐skins, the TE‐skin can dynamically termoregulate according to the surrounding temperature through a phase change. Combining with the principle of triboelectric nanogenerator, the TE‐skin is also able to act as a self‐powered sensor. Based on the self‐powered TE‐skin, an intelligent dialing communications system is further developed, which can be used to call a cellphone on human skin. For the first time, this study introduces the dynamic thermoregulating concept to E‐skins and could open up new opportunities for E‐skin developments.

No abstract

Background Colon cancer is a most common malignant cancer in digestive system, and it is prone to develop resistance to the commonly used chemotherapy drugs, leading to local recurrence and metastasis. Paris saponin VII (PSVII) could not only inhibit the proliferation of colon cancer cells but also effectively induce apoptosis of drug-resistant colon cancer cells and reduce the metastasis of drug-resistant colon cancer cells as well. However, PSVII was insoluble in water and fat. It displayed no selective distribution in body and could cause severe hemolysis. Herein, colon cancer targeting calcium phosphate nanoparticles were developed to carry PSVII to treat drug-resistant colon cancer. Results PSVII carboxymethyl-β-cyclodextrin inclusion compound was successfully encapsulated in colon cancer targeting calcium phosphate nanoparticles (PSVII@MCP-CaP) by using modified citrus pectin as stabilizer agent and colon cancer cell targeting moiety. PSVII@MCP-CaP significantly reduced the hemolysis of PSVII. Moreover, by specific accumulating in orthotopic drug-resistant colon cancer tissue, PSVII@MCP-CaP markedly inhibited the growth of orthotopic drug-resistant colon cancer in nude mice. PSVII@MCP-CaP promoted the apoptosis of drug-resistant colon cancer cells through mitochondria-mediated apoptosis pathway. Moreover, PSVII@MCP-CaP significantly inhibited the invasion and migration of drug-resistant colon cancer cells by increasing E-cadherin protein expression and reducing N-cadherin and MMP-9 protein expression. Conclusion PSVII@MCP-CaP has great potential in the treatment of drug-resistant colon cancer. This study also explores a new method to prepare active targeting calcium phosphate nanoparticles loaded with a fat and water insoluble compound in water. Graphical Abstract

No abstract